Malignant tumor of pancreas (disorder)
Clinical Trial: SPARC
Year Started: 2015
A phase 1 trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
-
No restrictions
Associated Data Type |
Procurement Timeframe |
Followup records |
0 - 3 months |
Imaging data |
0 - 3 months |
Pathology records |
0 - 3 months |
Physiological/biochemical measurements |
0 - 3 months |
Treatment records |
0 - 3 months |
Male
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Whole blood |
|
-60°C to -85°C |
N/A |
Not applicable |
0 - 10% |
Female
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Whole blood |
|
-60°C to -85°C |
N/A |
Not applicable |
0 - 10% |
Male
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Peripheral blood mononuclear cells (PBMC) |
|
-60°C to -85°C |
N/A |
Not applicable |
0 - 10% |
Female
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Peripheral blood mononuclear cells (PBMC) |
|
-60°C to -85°C |
N/A |
Not applicable |
0 - 10% |
Male
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Plasma |
|
-60°C to -85°C |
N/A |
Not applicable |
0 - 10% |
Female
Adult (> 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Plasma |
|
-60°C to -85°C |
N/A |
Not applicable |
0 - 10% |
Malignant tumor of rectum (disorder)
Clinical Trial: CEDAR
Year Started: 2019
A Phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer
- Access:
- Access restricted at present
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
-
No restrictions
Associated Data Type |
Procurement Timeframe |
There is no associated data for this collection. |
Female
Young adult (18 - 40 years)
1 - 10 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Faeces |
|
RT |
|
Not applicable |
0 - 10% |
RNA |
|
-60°C to -85°C |
|
Not applicable |
0 - 10% |
Tissue specimen |
|
RT |
Paraffin |
Not applicable |
0 - 10% |
Whole blood |
|
RT |
|
Not applicable |
0 - 10% |
Female
Adult (> 40 years)
1 - 10 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Faeces |
|
RT |
|
Not applicable |
0 - 10% |
RNA |
|
-60°C to -85°C |
|
Not applicable |
0 - 10% |
Tissue specimen |
|
RT |
Paraffin |
Not applicable |
0 - 10% |
Whole blood |
|
RT |
|
Not applicable |
0 - 10% |
Male
Young adult (18 - 40 years)
1 - 10 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
RNA |
|
-60°C to -85°C |
|
Not applicable |
0 - 10% |
Tissue specimen |
|
RT |
|
Not applicable |
0 - 10% |
Whole blood |
|
RT |
|
Not applicable |
0 - 10% |
Faeces |
|
RT |
|
Not applicable |
0 - 10% |
Male
Adult (> 40 years)
1 - 10 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Faeces |
|
RT |
|
Not applicable |
0 - 10% |
RNA |
|
-60°C to -85°C |
|
Not applicable |
0 - 10% |
Tissue specimen |
|
RT |
|
Not applicable |
0 - 10% |
Whole blood |
|
RT |
|
Not applicable |
0 - 10% |